SINBON Electronics Establishes Clayton, Ohio, Operations
08/26/2025
The investment includes the renovation of an existing 59,000-square-foot facility which will serve as the hub in the company’s network of warehouses in the U.S. to streamline logistics and material flows.
"By opening the new SINBON facility in Ohio, we have expanded our role in strengthening US value chains and empowering our customers," said Joy Wu, Vice President, Industrial Business Unit at SINBON. "Establishing a stronger presence in the heart of US manufacturing means we can collaborate more closely, respond faster to evolving needs, and deliver solutions that drive innovation and resilience when it matters most."
SINBON Electronics provides integrated design and manufacturing services for electronic components and interconnect solutions, including cable assemblies, antennas, and connectors. The company serves the medical, automotive, industrial, green energy, and consumer electronics sectors, offering services from raw material sourcing and design to manufacturing, logistics, and after-sales support.
Project Announcements
Kratos Plans Somerset County, Maryland, Production Operations
01/17/2026
CesiumAstro Expands Bee Cave, Texas, Headquarters-Manufacturing Operations
01/16/2026
Johnson & Johnson Expands Wilson County, North Carolina, Production Operations
01/16/2026
Solstice Advanced Materials Expands Chesterfield County, Virginia, Manufacturing Operations
01/16/2026
TransMedics Group Plans Somerville, Massachusetts, Headquarters Operations
01/16/2026
AVAIO Digital Partners Plans Pulaski County, Arkansas, Data Center Operations
01/14/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The New Industrial Revolution in Biotech
Q4 2025